Page last updated: 2024-08-26

cyanopindolol and Lymphoma, Non-Hodgkin

cyanopindolol has been researched along with Lymphoma, Non-Hodgkin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Emmerich, B; Göhly, U; Haen, E; Hallek, M; Kamp, T; Remien, J	1

Other Studies

1 other study(ies) available for cyanopindolol and Lymphoma, Non-Hodgkin

Article	Year
Reduced responsiveness of adenylate cyclase to forskolin in human lymphoma cells. Biochemical pharmacology, 1991, Sep-12, Volume: 42, Issue:7 Topics: Adenylyl Cyclase Inhibitors; Aged; B-Lymphocytes; Binding Sites; Cholera Toxin; Colforsin; Cyclic AMP; Female; Humans; Isoproterenol; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pindolol; Receptors, Adrenergic, beta; Signal Transduction; Tumor Cells, Cultured	1991

Article

Year

Reduced responsiveness of adenylate cyclase to forskolin in human lymphoma cells.

Biochemical pharmacology, 1991, Sep-12, Volume: 42, Issue:7

Topics: Adenylyl Cyclase Inhibitors; Aged; B-Lymphocytes; Binding Sites; Cholera Toxin; Colforsin; Cyclic AMP; Female; Humans; Isoproterenol; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pindolol; Receptors, Adrenergic, beta; Signal Transduction; Tumor Cells, Cultured

1991